thus possible that, during the establishment of HDAC3 -/-cell lines, cell subpopulations in which the loss of HDAC3 was compensated for progression into mitosis, but not for the DNA damage response, were selected. In addition, as suggested by Bhaskara et al. 2008 and illustrated by the higher level of cell mortality in HDAC3 -/-transformed cells than in HDAC3 -/-MEFs, HDAC3 null mitotic defects may be specific to immortalized cells. Finally, given that our observations and those of other groups on the relationship between HDAC3 depletion and blockage in G2/M (Wilson et al. 2006 ) and mitotic defects (Li et al. 2006; Ishii et al. 2008) were carried out in human transformed cell lines, a species-specific role of HDAC3 in mitosis cannot be excluded.
Note S2:
As shown for antibodies against H3S10Ph, the binding of antibodies targeting a specific posttranslational modification may be hampered by neighboring modifications (Clayton et al. 2000) . The decrease in H3S10Ph labeling reported by Li et al. (2006) may therefore result from epitope masking due to the acetylation of a neighboring lysine residue induced by HDAC3 depletion. The two anti-H3S10Ph antibodies used here recognize H3S10Ph, even in the context of hyperacetylated mitotic chromosomes ( Figure S2B ).
Note S3:
The anti-H3K4Ac antibody described by Garcia et al. (2007) showed cross-reactivity with H4K5Ac. We therefore investigated the specificity of the antibody used in our study. Western blot experiments showed that this antibody recognized a single band of the expected size for H3, although H4K5Ac was present in the sample and was detected with the corresponding antibody ( Figure S10A ). Moreover, immunoblots on HDAC3-depleted and control cells blocked in mitosis (to decrease the background of non centromeric interphasic H3K4Ac) with the anti-H3K4Ac antibody showed a modest, but reproducible increase in H3K4 acetylation in HDAC3-depeleted cells, possibly corresponding to centromeric H3K4Ac ( Figure S10B ).
Competition experiments showed that the centromeric H3K4Ac signal in HDAC3-depleted cells was lost only if an H3K4Ac peptide was used as a competitor ( Figure S10C ). Thus, the anti-H3K4Ac antibody used specifically recognized acetylated H3K4 and did not cross-react with H4K5Ac.
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Supplemental figure legends:
Figure S1
:
No increase in mitotic index or PSCS is observed in cells depleted for HDAC1 or HDAC2.
(A) HeLa cells were transfected with the indicated siRNA, on days 1 and 2, and mitotic cells were scored by microscopy on day 4. At least 500 cells were counted for each experimental point. Data are means and SD from three independent experiments. The depletion of both MAD2 and HDAC3 does not affect the level of HDAC3 depletion.
HDAC3 depletion does not lead to the loss of H3S10 phosphorylation in mitotic cells
All siRNA codepletion experiments were carried out with the same total amount of siRNA and, when a single relevant siRNA was used, a second transfection with a control siRNA (GFP) was always performed. Accordingly, the control (GFP alone) transfection was performed with twice the amount of siRNA used in a single transfection. Codepletion of Plk1 or Aurora B with HDAC3 had no effect on the level of HDAC3 depletion.
We could not investigate whether the effects of Aurora B and Plk1 on chromatid cohesion were additive because the depletion of both Aurora B and Plk1 led to massive cell death.
However, previous experiments in cell-free extracts have suggested that the effects of Plk1
and Aurora B on cohesin dissociation in mitosis are additive rather than redundant (Losada et al. 2002) . All siRNA codepletion experiments were carried out with the same total amount of siRNA and, when a single relevant siRNA was used, a second transfection with a control siRNA (GFP) was always performed. Accordingly, the control (GFP alone) transfection was performed with twice the amount of siRNA used in a single transfection. Immunofluorescence was analyzed on day 5. 
H3K4Ac centromeric labeling is not observed following depletion of HDAC1 or HDAC2 and centromeric acetylation of H3K9 and H4K5 is not detected following the depletion of HDAC1, 2 or 3 (A) Immunofluorescence microscopy on control mitotic cells (siRNA GFP).
H3K4Ac, H3K9Ac, H4K5Ac, CREST and DNA staining is shown. Cells were transfected with GFP siRNA on days 1 and 2. Immunofluorescence was analyzed on day 5.
(B) Immunofluorescence microscopy on HDAC1-depleted mitotic cells. H3K4Ac, H3K9Ac, H4K5Ac, CREST and DNA staining is shown. Transfection parameters were as in Figure   S11A .
(C) Immunofluorescence microscopy on HDAC2-depleted mitotic cells. H3K4Ac, H3K9Ac, H4K5Ac, CREST and DNA staining is shown. Transfection parameters were as in Figure   S11A .
(D) Immunofluorescence microscopy on HDAC3-depleted mitotic cells (siRNA HDAC3-1).
H3K4Ac, H3K9Ac, H4K5Ac, CREST and DNA staining is shown. Transfection parameters were as in Figure S11A . and control eGFP siRNAs (Nagy et al. 2003; Kitajima et al. 2005) were purchased from QIAGEN. Aurora B and Plk1 siRNAs (Qi et al. 2006) were synthesized by Dharmacon.
Immunoblotting
For histone H3 immunoblotting, cells were lysed in Laemmli buffer (50% glycerol, 6% SDS, 0.1% bromophenol blue, 10% β-mercaptoethanol) and boiled for 5 minutes. , 1997-2005) .
Mitotic chromosome spreads
Cells were released by incubation with trypsin and collected in their culture medium supplemented with eight volumes of 75 mM KCl, prewarmed at 37°C. After incubation for 20 minutes at 37°C, one volume of fixative solution (ethanol/acetate 3:1) was added and chromosomes were washed five times in fixative solution. An aliquot (25 μl) of each sample was spotted onto a glass slide, allowed to dry in air for 1 to 2 h at room temperature and stained with DAPI (100 ng/ml). Microscope slides were mounted in Mowiol. For the monitoring of chromosome spreading by immunostaining, 30,000 cells were incubated in 75 mM KCl and cytocentrifuged in a CYTOSPIN (Shandon) for 5 minutes at 1300 rpm before fixation in 3% paraformaldehyde solution. Immunostaining was carried out as described above.
HDAC3 in vitro activity assay
The FLAG-HDAC3 expression vector has been described elsewhere (Emiliani et al. 1998) and was obtained from Addgene. Site-directed mutagenesis was carried out by double PCR, to obtain a mutant FLAG-HDAC3-Y298F construct lacking HDAC activity (Lahm et al. 2007 ).
The coding sequence of HDAC3 was entirely resequenced to ensure the absence of unwanted mutations.
Cos cells were transfected with empty pCDNA3.1 vector (Invitrogen), pFLAG-HDAC3 and pFLAG-HDAC3-Y298F constructs. After incubation for 48 hours, cells were lysed by incubation in 300 mM NaCl, 10 mM MgCl 2 , 0.4% NP-40, 50 mM Tris pH 8. Cell lysates were subjected to overnight immunoprecipitation with an anti-FLAG antibody (3 µg/ml) at with an anti-HDAC3 antibody, to ensure that comparable amounts of FLAG-HDAC3 protein were present in the relevant samples.
